Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
Multicomponent interdisciplinary group intervention for self-management of fibromyalgia: a mixed-methods randomized
Patricia Bourgault1, Anaïs Lacasse2, Serge Marchand3
1École des sciences infirmières, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, QC, Canada; Centre de recherche clinique Étienne-Le Bel du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.
The PASSAGE Program improved fibromyalgia patients' sense of control over symptoms, with significant positive patient-reported outcomes. While not impacting primary pain measures, the intervention showed lasting benefits in self-management for fibromyalgia syndrome (FMS).
Area of Science:
- Fibromyalgia research
- Interdisciplinary group interventions
- Self-management strategies
Background:
- Fibromyalgia syndrome (FMS) is a chronic condition requiring effective management strategies.
- The PASSAGE Program is a structured, multicomponent, interdisciplinary group intervention designed for FMS self-management.
Purpose of the Study:
- To evaluate the efficacy of the PASSAGE Program for FMS self-management.
- To assess the impact of the intervention on pain intensity, fibromyalgia severity, and quality of life.
Main Methods:
- A mixed-methods randomized controlled trial (RCT) comparing the intervention (INT) group to a waitlist (WL) control group.
- Data collection at baseline (T0), end of intervention (T1), and 3-month follow-up (T2).
- Primary outcome: change in pain intensity; Secondary outcomes: various patient-reported measures including Patient Global Impression of Change (PGIC).
Main Results:
- The PASSAGE Program significantly improved Patient Global Impression of Change (PGIC) measures for pain, functioning, and quality of life compared to the waitlist group.
- These improvements were sustained at 3-month follow-up.
- A higher proportion of patients in the intervention group reported significant pain relief (≥50%) at both T1 and T2.
- Qualitative data supported the quantitative findings on intervention efficacy.
- No significant improvements were observed in the primary outcome (pain intensity) or other secondary outcome measures.
Conclusions:
- The PASSAGE Program effectively enhanced FMS patients' perceived control over their symptoms.
- Patient Global Impression of Change (PGIC) measures appear valuable for capturing patient experiences in FMS clinical trials.
Related Concept Videos
Irritable Bowel Syndrome III: Medical and Nursing Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Chronic Pancreatitis II: Collaborative Care
Assessment:
Rheumatic Heart Disease III: Medical Management
